Duke Cancer Institute Announces New Thyroid Cancer Center
The Duke Cancer Institute has launched the Thyroid Cancer Center, a multidisciplinary hub dedicated to delivering the highest level of care for patients with thyroid disease.
The Duke Cancer Institute has launched a multidisciplinary Thyroid Cancer Center dedicated to delivering comprehensive care for patients with thyroid disease.
Launching a specialized center improves access to coordinated, evidence‑based treatment and supports advanced diagnostics and personalized care for thyroid cancer patients.
Bizonyítékszint: Számítógépes vagy elméleti. Modellből vagy adatbányászatból származó jel.
Kapcsolódó jelek
- The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma
- The molecular mechanisms and potential therapeutic implications of the crosstalk between DNA methylation and metabolic reprogramming in thyroid cancer
- Improving predicted risk of recurrence using molecular profiling in papillary thyroid cancer
- Global Burden of Thyroid Cancer in Adults Age 15‑49 Years and Its Predictions: Findings From Global Burden of Disease Study 2021
- Thyroid Cancer: Pathogenesis, Clinicopathology, Diagnosis, and Management